SVNS — Solvonis Therapeutics Share News
0.000.00%
Brief: Solvonis Therapeutics Announces £1 Mln Subscription To Accelerate AI Drug Discovery
Solvonis Therapeutic - £1m subscription to accelerate AI drug discovery
Solvonis Therapeutic - Holding(s) in Company
Solvonis Therapeutic - AGM Statement
Solvonis Therapeutic - Holding(s) in Company
RCS - Solvonis Therapeutic - Initiation of Research Coverage
Solvonis Therapeutic - Allowance of U.S. patent covering AI-supported CNS
Solvonis Therapeutic - Initiation of AI supported CNS drug discovery
Solvonis Therapeutic - Synthesis of development candidate for SVN-SDN-014
Solvonis Therapeutic - Notice of Annual General Meeting
Solvonis Therapeutic - Appointment of Prof. David Nutt as CSO
Solvonis Therapeutic - Holding(s) in Company
Solvonis Therapeutic - Holding(s) in Company
Solvonis Therapeutic - Holding(s) in Company
Solvonis Therapeutic - Holding(s) in Company
RCS - Solvonis Therapeutic - Presentation at Mello2025
Solvonis Therapeutic - Holding(s) in Company
Solvonis Therapeutic - Completion of the acquisition of Awakn
Solvonis Therapeutic - Result of placing